Market Segmentation
- ESRD Treatment Outlook (Revenue, USD Million, 2018 - 2030)
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- ESRD Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- U.S.
- U.S. End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- U.S. End Stage Renal Disease Market, By Treatment
- Canada
- Canada End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Canada End Stage Renal Disease Market, By Treatment
- North America End Stage Renal Disease Market, By Treatment
- Europe
- Europe End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- U.K.
- U.K. End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- U.K. End Stage Renal Disease Market, By Treatment
- Germany
- Germany End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Germany End Stage Renal Disease Market, By Treatment
- France
- France End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- France End Stage Renal Disease Market, By Treatment
- Italy
- Italy End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Italy End Stage Renal Disease Market, By Treatment
- Spain
- Spain End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Spain End Stage Renal Disease Market, By Treatment
- Denmark
- Denmark End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Denmark End Stage Renal Disease Market, By Treatment
- Sweden
- Sweden End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Sweden End Stage Renal Disease Market, By Treatment
- Norway
- Norway End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Norway End Stage Renal Disease Market, By Treatment
- Europe End Stage Renal Disease Market, By Treatment
- Asia Pacific
- Asia Pacific End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- China
- China End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- China End Stage Renal Disease Market, By Treatment
- Japan
- Japan End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Japan End Stage Renal Disease Market, By Treatment
- India
- India End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- India End Stage Renal Disease Market, By Treatment
- Australia
- Australia End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Australia End Stage Renal Disease Market, By Treatment
- South Korea
- South Korea End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- South Korea End Stage Renal Disease Market, By Treatment
- Thailand
- Thailand End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Thailand End Stage Renal Disease Market, By Treatment
- Asia Pacific End Stage Renal Disease Market, By Treatment
- Latin America
- Latin America End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Brazil
- Brazil End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Brazil End Stage Renal Disease Market, By Treatment
- Mexico
- Mexico End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Mexico End Stage Renal Disease Market, By Treatment
- Argentina
- Argentina End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Argentina End Stage Renal Disease Market, By Treatment
- Colombia
- Colombia End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Colombia End Stage Renal Disease Market, By Treatment
- Latin America End Stage Renal Disease Market, By Treatment
- Middle East & Africa
- Middle East & Africa End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- South Africa
- South Africa End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- South Africa End Stage Renal Disease Market, By Treatment
- Saudi Arabia
- Saudi Arabia End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Saudi Arabia End Stage Renal Disease Market, By Treatment
- UAE
- UAE End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- UAE End Stage Renal Disease Market, By Treatment
- Kuwait
- Kuwait End Stage Renal Disease Market, By Treatment
- Transplant
- Dialysis
- Peritoneal Dialysis
- Hemodialysis
- Wearable artificial Kidney
- Kuwait End Stage Renal Disease Market, By Treatment
- Middle East & Africa End Stage Renal Disease Market, By Treatment
- North America
End Stage Renal Disease Market Market Dynamics
Driver: Rising global prevalence of CKDs
Any condition that causes reduced kidney function leads to chronic kidney disease, which may develop over a while and result in End-Stage Renal Disease (ESRD). Chronic kidney disease is one of the major factors responsible for increasing kidney failure rates among patients. According to the Global Burden of Disease Study (WHO), in 2015, renal disease was the twelfth most common cause of death, accounting for 1.2 million deaths globally. According to National Kidney Foundation (NKF), there are more than 2 million people around the world suffering from chronic kidney disease, and millions of people die from this condition every year. The number of patients continues to increase at a rate of 5% to 7% per year, and patients require kidney transplants or dialysis to survive. It is also estimated that the number of renal failure cases will increase, especially in developing countries such as China and India among elderly people, since the geriatric population is more susceptible to renal problems. Approximately 80 million people, which is around 1 in 3 American adults, are at risk of chronic kidney disease. It is the ninth leading cause of death in the U.S. According to the National Institute of Diabetes and Digestive and Kidney Disease statistics, in 2017, more than 500,000 patients underwent dialysis treatment. More than 200,000 people are living with a kidney transplant. Thus, the increasing incidence of chronic kidney disease, which leads to ESRD, is expected to fuel market growth.
Restraint: Expensive equipment impacting their affordability in developing nations
With advancements in technology, devices with new features have been introduced in the market. With the addition of features, the cost of the product increases, thereby reducing the affordability for most patients, especially in low- and middle-income countries. For instance, the integration of intelligent guideline technology for real-time patient monitoring during Peritoneal Dialysis (PD) allows physicians and care teams to monitor dialysis doses during therapy. Similarly, the launch of a fully automated PD device with a remote patient management platform guide to treat ESRD patients through home PD therapy and simultaneously remotely connect them with their healthcare providers increases the cost of therapy owing to the use of expensive materials. Furthermore, advanced systems need a relatively expensive and elaborate setup. Specially trained clinicians are also required to operate these devices, which increases their cost. Thus, poor patients living in low-income countries cannot afford these systems, which may restrain the market growth.
Opportunity: Rising demand for home care services in the post-pandemic period
The demand for home care services has increased over the years and is expected to further increase due to the coronavirus outbreak. Home health service providers are offering multiple home care services, including delivery of medicines and purchase or rent of dialysis-related equipment. The outbreak of COVID-19 created large-scale opportunities for local manufacturers. Due to restrictions on movement at international borders, the supply chain of major players was disrupted. This created an opportunity for local players to enter the market and meet the demands of end users. The rising number of cases led to a shortage of medical supplies, thus local players manufactured products on a larger scale to meet this need. Furthermore, healthcare facilities such as hospitals were exhausted with a large number of coronavirus patients; therefore, many countries postponed elective surgeries and other renal care procedures for an indefinite period. Thus, patients suffering from acute and chronic kidney diseases were treated at home or outpatient facilities. Hence, the demand for renal home therapies increased. In addition, many patients adopted online counseling for their health-related concerns. This is likely to fuel market growth during the forecast period.
What Does This Report Include?
This section will provide insights into the contents included in this end stage renal disease market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
End stage renal disease market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
End stage renal disease market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
